FLGT

Fulgent Genetics, Inc.

Fulgent Genetics, Inc. (FLGT) has 17 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 28, 2026.

Insiders have net sold $106K over the trailing 6 months.

  • Industry:Medical - Diagnostics & Research
  • CEO:Ming Hsieh
  • Employees:1,313
  • HQ:El Monte, CA, US
  • IPO:2016-09-29

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$106K

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$574.0M

latest known value

Source
Sale$38KJun 3SEC ↗
Sale$30KJun 3SEC ↗
Xie JianFirst filing
Sale$21KMay 28SEC ↗
Gao HanlinFirst filing
Sale$17KMay 28SEC ↗

Related companies

Fulgent Genetics, Inc. is in the Healthcare sector.